Order Article Reprints

Tallarico M, Palleria C, Ruffolo L, Spagnuolo R, Naturale MD, De Francesco AE, De Sarro C, Romeo R, Citraro R, Doldo P, et al. Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study. Pharmaceutics. 2022; 14(11):2449. https://doi.org/10.3390/pharmaceutics14112449

Tallarico, Martina, Caterina Palleria, Livia Ruffolo, Rocco Spagnuolo, Maria Diana Naturale, Adele Emanuela De Francesco, Caterina De Sarro, Rossella Romeo, Rita Citraro, Patrizia Doldo, and et al. 2022. "Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study" Pharmaceutics 14, no. 11: 2449. https://doi.org/10.3390/pharmaceutics14112449

Tallarico, M., Palleria, C., Ruffolo, L., Spagnuolo, R., Naturale, M. D., De Francesco, A. E., De Sarro, C., Romeo, R., Citraro, R., Doldo, P., Abenavoli, L., Gallelli, L., Luzza, F., Leo, A., & De Sarro, G. (2022). Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study. Pharmaceutics, 14(11), 2449. https://doi.org/10.3390/pharmaceutics14112449